3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
1
Thymoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
SCLC, Extensive Stage
1
Resectable Esophageal Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Neoplasms
1
NSCLC
1
Mouth Neoplasms
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Resectable Esophageal Cancer
×
Chemoradiotherapy
×
Clear all
NCT07385664
2026-02-04
FAIR
Zhejiang Cancer Hospital
Phase 2
Not yet recruiting
66 enrolled